| __timestamp | Dyne Therapeutics, Inc. | Ionis Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 1145000000 | 241751000 |
| Thursday, January 1, 2015 | 2028000000 | 322292000 |
| Friday, January 1, 2016 | 2281000000 | 344320000 |
| Sunday, January 1, 2017 | 2932000000 | 374644000 |
| Monday, January 1, 2018 | 24000 | 1820000 |
| Tuesday, January 1, 2019 | 271000 | 4000000 |
| Wednesday, January 1, 2020 | 700000 | 12000000 |
| Friday, January 1, 2021 | 1088000 | 11000000 |
| Saturday, January 1, 2022 | 3345000 | 14000000 |
| Sunday, January 1, 2023 | 2461000 | 9133000 |
| Monday, January 1, 2024 | 11215000 |
Cracking the code
In the dynamic world of biotechnology, cost efficiency is a critical factor for success. This analysis delves into the cost of revenue trends for Ionis Pharmaceuticals, Inc. and Dyne Therapeutics, Inc. from 2014 to 2023. Ionis Pharmaceuticals, known for its innovative RNA-targeted therapies, has shown a relatively stable cost of revenue, peaking in 2017 with a 37% increase from 2014. In contrast, Dyne Therapeutics, a newer player in the field, experienced a dramatic fluctuation, with costs skyrocketing by over 150% from 2014 to 2017, before stabilizing in recent years. This disparity highlights the challenges and growth phases of emerging biotech firms compared to more established companies. As the industry evolves, understanding these financial dynamics is crucial for investors and stakeholders aiming to navigate the biotech landscape effectively.
Cost of Revenue Trends: Bristol-Myers Squibb Company vs Ionis Pharmaceuticals, Inc.
Comparing Cost of Revenue Efficiency: Intra-Cellular Therapies, Inc. vs Ionis Pharmaceuticals, Inc.
Bio-Techne Corporation vs Dyne Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: BioMarin Pharmaceutical Inc. and Ionis Pharmaceuticals, Inc.
Cost of Revenue Trends: Catalent, Inc. vs Dyne Therapeutics, Inc.
Cost of Revenue Comparison: Walgreens Boots Alliance, Inc. vs Dyne Therapeutics, Inc.
Comparing Cost of Revenue Efficiency: Jazz Pharmaceuticals plc vs Ionis Pharmaceuticals, Inc.
Cost of Revenue Comparison: Jazz Pharmaceuticals plc vs Dyne Therapeutics, Inc.
Cost of Revenue Trends: Pharming Group N.V. vs Ionis Pharmaceuticals, Inc.
Comparing Cost of Revenue Efficiency: Ionis Pharmaceuticals, Inc. vs Vericel Corporation
Cost of Revenue Comparison: CRISPR Therapeutics AG vs Dyne Therapeutics, Inc.
Cost Insights: Breaking Down Veracyte, Inc. and Dyne Therapeutics, Inc.'s Expenses